当前位置:首页 - 行情中心 - 亨迪药业(301211) - 财务分析

亨迪药业

(301211)

  

流通市值:50.34亿  总市值:50.34亿
流通股本:2.88亿   总股本:2.88亿

亨迪药业(301211)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润0.10亿元,每股收益0.04元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益232090.74万元,未分配利润21788.08万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产247156.56万元,负债15065.82万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入114,446,404.92445,864,331.31333,993,687.09241,866,955.11
营业总成本110,957,953.42366,995,322.83263,843,342.98164,433,150.68
营业利润12,516,274.71100,882,007.9682,958,023.6681,129,769.44
利润总额12,500,267.77100,419,009.7882,580,556.8380,885,172.5
净利润10,326,085.3591,547,379.7874,661,546.2868,496,011.31
其他综合收益--303,688.04--
综合收益总额10,326,085.3591,243,691.7474,661,546.2868,496,011.31
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计1,859,505,802.431,874,616,455.241,876,829,237.791,901,026,904.25
非流动资产合计612,059,841.06614,039,238.77560,239,858.04527,792,548.05
资产总计2,471,565,643.492,488,655,694.012,437,069,095.832,428,819,452.3
流动负债合计136,031,218.71164,383,819.5128,361,400.85126,960,878.85
非流动负债合计14,626,998.3514,583,341.3513,278,812.7213,635,299.82
负债合计150,658,217.06178,967,160.85141,640,213.57140,596,178.67
归属于母公司股东权益合计2,320,907,426.432,309,688,533.162,295,428,882.262,288,223,273.63
股东权益合计2,320,907,426.432,309,688,533.162,295,428,882.262,288,223,273.63
负债和股东权益合计2,471,565,643.492,488,655,694.012,437,069,095.832,428,819,452.3
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计107,071,652.45460,553,003.21358,511,330252,111,623.06
经营活动现金流出小计101,014,670.69364,479,760.32309,552,700.22220,153,835.39
经营活动产生的现金流量净额6,056,981.7696,073,242.8948,958,629.7831,957,787.67
投资活动现金流入小计22,148,082.3499,313,723.1788,261,830.3177,252,650.31
投资活动现金流出小计76,763,976.341,208,775,497.961,173,472,855.41644,032,788.11
投资活动产生的现金流量净额-54,615,894-1,109,461,774.79-1,085,211,025.1-566,780,137.8
筹资活动现金流入小计----
筹资活动现金流出小计-139,871,461.88138,240,000138,240,000
筹资活动产生的现金流量净额--139,871,461.88-138,240,000-138,240,000
汇率变动对现金及现金等价物的影响149,007.982,073,270.73910,901.581,397,535.02
现金及现金等价物净增加额-48,409,904.26-1,151,186,723.05-1,173,581,493.74-671,664,815.11
期末现金及现金等价物余额494,729,887.37543,039,791.63520,745,020.941,022,661,699.57
TOP↑